AHA 2017Lipid Lowering Therapy Residual Inflammatory Risk and Residual Cholesterol Risk: CANTOS Trial Medhat Share 0 Min Read http://cardiologynownews.org/wp-content/uploads/2017/12/2112-2084.mp4 TAGGED:AHA 2017CANTOSCholesterolConference Share This Article Copy Link Print Leave a Comment Leave a Reply Cancel replyYou must be logged in to post a comment.
